{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"LTE60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Eligibility for this study was expanded from measurable, stage 3 or stage 4 or recurrent disease to include non-measurable, stage 4 or recurrent disease and then to include non-measurable stage 3 disease."},"pointOfContact":{"email":"lgedeon@gogstats.org","organization":"NRG Oncology","phone":"716-545-8321","title":"Linda Gedeon for Virginia Filiaci, PhD."}}